Fibroblasts mediate T cell survival: a proposed mechanism for retention of primed T cells by unknown
BriefDefinitive Report
Fibroblasts Mediate T Cell Survival: A Proposed
Mechanism for Retention of Primed T Cells
By Sumi Scott, Franco Pandolfi, and James T. Kurnick
From the Department of Pathology, Massachusetts General Hospital,
Harvard Medical School, Boston, Massachusetts 02114
Summary
This report describes a salvage pathway whereby activated T lymphocytes revert to nonproliferating
cells in the absence of antigen or mitogenic signals. After the removal of mitogenic cytokines,
cultured T lymphocytes cease dividing and rapidly begin to undergo cell death. However, the
addition of fibroblasts to interleukin 2 (IL2)-propagated T cells results in prolonged survival
of the previously activated T lymphocytes in the absence of proliferation. The prevention of
cell death is also achieved by conditioned medium from the fibroblasts. T lymphocytes cultured
with fibroblasts or the conditioned medium retain the ability to be restimulated if mitogenic
stimuli are added to the culture. The activity is not accounted for by ILl-7. The studies suggest
a stromal cell-mediated, nonspecific mechanism for survival of primed T lymphocytes in a
nonproliferating state.
Lmphocyte responses to antigens can be divided into three
main phases: (a) antigen-driven activation; (b) clonal ex-
pansion and differentiation of effector cells; and (c) after
removal of antigen, the retention of "primed" cells, which
allows an accelerated response upon antigenic rechallenge. Al-
though many details on the first two phases are understood;
little is known about how primed cells are preserved. In fact,
when activated cells are removed from the presence of anti-
genic stimuli or proliferation-inducing cytokines, they rap-
idly cease dividing and begin to deteriorate (1). We have
observed that the presence of the tissue enhanced the sur-
vival and activation of T lymphocytes (2). Stimulatory an-
tigens could account for this enhanced activation (3), but
we have now shown that fibroblasts alone, or even superna-
tants derived from fibroblast cultures, are also able to sup-
port the survival of T lymphocytes.
Materials and Methods
Culture ofFibroblastsandPreparation ofFibroblast-conditioned Medium
(FCM). Fragments of synovial tissues were obtained from patients
undergoing surgery for destructivejoint disease from chronic rheu-
matoid arthritis (RA) in order to obtain parallel cultures of ad-
herent synovial fibroblasts and IL-2-dependant T lymphocytes, as
previously described (4). A cell-free supernatant from the fibro-
blasts, or fibroblast conditioned medium (FCM), was prepared by
collecting the spent 3-4-d conditioned medium from the cultures
of confluent fibroblasts.
Cultures ofTLymphocytes.
￿
Human T lymphocytes were propa-
gated in long-term culture using rIIJ2 at 10 U/ml (2). T cells were
obtained from peripheral blood stimulated with 1 ug/ml PHA,
and from inflamed tissues, including allograftsand rheumatoid sy-
novia, from which the infiltrating lymphocytes were propagated
in IL2, as reported (2, 4) . Such cultured lymphocytes generally
will divide in response to IL2 for a period ofup to 4 wk, at which
time log phase growth requires restimulation ofIIL2Rs, with PHA
and irradiated mononuclear cells (5). If IL2 is withdrawn, T cells
rapidly cease dividing and begin to die unless substitute stimuli
are provided.
Lymphocyte-Fibroblast Coculture and FCM Assay.
￿
To test the
effects on lymphocyte survival, T cells were cocultured with the
synovial fibroblasts (isolated as above) in the absence of any added
cytokines. Viability was assessed microscopically. For proliferation
studies, the fibroblasts were irradiated with "'Cs (3,000 rad). Peri-
odically, lymphocyte aliquots were placed into individual wells of
96-well plates to monitor cell proliferation in 4-h [3H]thymidine
incorporation assays. At various intervals, IL-2 (100 U/ml) was added
back to the T cell cultures, and both visual observations and deter-
minations of [3H]thymidine incorporation were made at 2-5 d
after re-addition of IL2.
PHA and irradiated feeder cells were added to test both viability
and proliferative capacity of the cultures. The T cell lines tested
included both clones and bulk culture lines obtained from RA pa-
tients (includingthe source of the synovial fibroblasts and unrelated
individuals), T cell lines, and clones ofboth CD4 and CDS pheno-
types from renal allografts.
Comparison between FCM and Some Known Cytokines.
￿
Com-
parisons were made between FCM and a group ofwell-characterized
cytokines (IIA-7). FCM was tested for ILl activity by the ability
of this medium to support the proliferation of the D10.G4.1 cell
line (6), and ILla and -/3 (kindly provided by DuPont de Nemours,
Inc., Wilmington, DE) were tested for theirability to prolong sur-
vival of the lymphocyte cultures in the FCM assay. The presence
of 11,2 in the FCM was assayed by the ability to induce prolifera-
tion of IL2-dependent human cell lines and murine CTLL (7). rIIL3,
-4, -5, and -6 were each tested for the ability to enhance T lympho-
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of FCM were tested for 11,7 activity by a bioassay on the 11,7-
dependent IxN/2b cell line (8) .
Results and Discussion
Fibroblasts Preserve T Lymphocyte Viability .
￿
The removal
of IL2-propagated T lymphocytes from medium containing
11,2 leads to the cessation of cell division and subsequent cell
death . When such IIr2-dependent cell lines are cocultured
with tissue or fibroblasts derived from inflamed synovium,
they also cease dividing, but, after clustering around the ad-
herent fibroblasts, many of the T cells remain viable for sev-
eral months. Although this could be the result of antigenic
stimulation, the observation that synovial fibroblasts had a
T cell viability preserving activity (TVPA) on several IL-2-
dependent T cell lines derived from different inflamed tissues
suggested a nonspecific fibroblast-mediated activity possibly
due to the production of one (or more) nonspecific cytokine(s).
As shown in Fig . 1, viable stableT cell cultures can be main-
tained for extended periods (> 8 mo at the time of manu-
script submission) in the presence of allogeneic fibroblasts.
Renewed division by these cells can be stimulated with PHA
and accessory cells. A similar phenomenon can be observed
when FCM is added to the T cells. In FCM, culture viability
is less dramatically extended, but live T cells can be main-
tained for as long as 6-8 wk only by periodic replenishment
ofFCM . In addition to synovial fibroblasts, FCM from dermal
fibroblasts can also extendT lymphocyte viability, although
such cells generally produce less TVPA than recently estab-
lished synovial fibroblasts . In the absence of 11,2 or FCM,
cell viability deteriorates much more rapidly, rarely being re-
tained for >10 d (Fig. 2) .
Although the synovial fibroblasts did not stimulate sig-
nificant proliferation among IIJ2-dependent T cells, they did
enhance IL-2 responsiveness of the primed lymphocytes. At
an optimal concentration of 5 x 10' fibroblasts/ml, lym-
phocytes (2 x 10 5/ml) showed approximately threefold en-
hanced IL2-driven proliferation (7,613 ± 2,333) vs. lympho-
cytes plus 11,2 (100 U/ml) without added fibroblasts (2,778
± 1,039) . As shown in Table 1, the fibroblast-enhanced 11,2
responsiveness can also be demonstrated by the supernatant
fluid from the fibroblasts .
FCM Preserves TLymphocyte Viability .
￿
Table 1 shows two
Figure 1.
￿
Survival of lymphocytes in presence of fibroblasts and FCM . Shown is the appearance of an IIT2-dependent T cell line (cultured from
a renal allograft [21) after 6mo (185 d) in the presence ofallogeneic synovial fibroblasts, which didnot induce proliferation . The appearance was virtually
identical after 8 mo of culture (x -1,000, main figure; x -300, inset) .
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Figure 2.
￿
The number of surviving primed T lymphocytes in 11,2 vs.
FCM vs. control medium over a 14-d period. Data shown are means of
triplicate experiments ofdifferent cultures derivedfrom tissue-derived lym-
phocytes.
types of assays to demonstratetheretained viability and acti-
vation ofthelymphocytes. To determineretained IL-2 respon-
siveness, IL2 was re-added at various times after culture in
I'M While IL2-depleted cells in control medium lose the
ability to respond to IL-2, together with the deterioration
of their viabilityafter3 d, the FCM-cultured cellsretain IL-2
responsiveness for the first 5 d, then diminish by 8 d, and
are nonproliferative in response to 1172 by 14 d. However,
the lack of proliferation in response to IL2 at this time is
not due to lost viability. In fact, the cells can be stimulated
Table 1.
￿
Preservation ofProliferative Potential by FCM
FCM was assayed for TVPA both in the presence and absence of added
IL-2. Parallel cultures of IL-2-dependent human T cells in DMEM with
5% FCS (with and without FCM) were established in tissue culture plates
at 2 x 105/ml. After varying periods of time, IL-2 (100 U/ml) was
added back to the cultures, and13H]thymidine incorporation was assayed
at 2 dafter readdition ofIL-2. Theability of theTcell cultures to respond
to mitogenic stimuli was further tested by the addition of PHA andir-
radiated APC as an indication ofboth viability andproliferative capacity
of the cultures.
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IL-2-propogated lymphocytes were washed andcultured 3d in FCMvs.
IL-6 (20 U/ml, also tested at between 100 and0.1 U/ml, not shown),
then IL-2 was re-added for 2 d before pulsingwith 1'H]thymidine. Anti-
IL-6 was used at a concentration sufficient to neutralize 20 U of IL-6.
IL-4 (shown at 25 U/ml., also tested at 5 and 2.5 U/ml); IL-3 (shown
at 10 U/ml, tested at 0.1-100 U/ml), and IL-5 (not stimulatory at any
dose tested >300-fold range) were compared with FCM.
with PHA in the presence of accessory cells, which allows
the resumption oflogphasegrowth andIL2 responsiveness.
Surface staining indicated that both CD4+ and CD8+
subsets of CD3+ T cells could be maintained in the pres-
ence of FCM. Although some cell death does occur in cul-
tures maintained in FCM without II:r2 for 14 d, there is
not a significant alteration in the proportions of CD4+ or
CD8+ T cells.
Comparison ofFCMwith Known Cytokines.
￿
Several known
cytokines were tested to determine if the TVPA was due to
a previously characterizedfactor. No 11,2 proliferation-inducing
activity was demonstrated in the FCM when tested on lIr2-
dependent human cell lines. IL-1, I1r3, IL4, and 11.75all failed
to prolong T cell line viability. IL6, which is known to en-
hance IL2 responsiveness (9), hadminimal TVPA-(Table 2).
Anti-11,6 antibody had minimal effect on the activity of the
FCM, indicating that this is not likely to be' an important
component of the TVPA. No IL1 was defected in'FCM as
determined in the D10-G4 proliferation assay. FCM alsq did
not contain detectable 11,7. FCM contained PGE2, but no
TVPA was observed using this, prostaglandin:.
Table 2. Comparison of FCM with Known Cytokines.
['H]Thymidine
Culture conditions Days without IL-2 incorporation
cpm
DMEM 3 131 ± 49
FCM 3 244 ± 50
IL-2 3 7,188 ± 1,477
IL-2 + FCM 3 19,082 ± 1,616
DMEM 3, then IL-2 3,923 ± 538
FCM 3, then IL-2 79,973 ± 7,403
IL-6 3, then IL-2 5,183 ± 292
FCM + anti-IL-6 3, then IL-2 65,590 ± 1,757
DMEM + anti-IL-6 3, then IL-2 1,429 ± 278
IL-6 + anti-IL-6 3, then IL-2 1,605 ± 68
DMEM 4, then IL-2 3,159 ± 367
FCM 4, then IL-2 12,268 ± 1,111
IL-4 4, then IL-2 3,137 ± 913
DMEM 2, then IL-2 3,477 ± 452
FCM 2, then IL-2 12,550 ± 2,331
IL-3 2, then IL-2 3,302 ± 664
IL-5 2, then IL-2 2,821 ± 789
Culture conditions
Days without
IL-2
['H]Thymidine
incorporation
cpm
DMEM 3 476 ± 206
FCM 3 29,238 ± 2,565
DMEM 5 181 ± 57
FCM 5 47,608 ± 7,209
DMEM 8 63 ± 55
FCM 8 6,135 ± 3,603
DMEM then PHA + APC 14 5,601 ± 256
FCM then PHA + APC 14 37,407 ± 3,021TVPA is produced constitutively for at leastseveral months
in cultured synovial fibroblasts and is not enhanced by stim-
ulation ofthe fibroblasts with ILA or IFN-y . Lower amounts
of TVPA couldalso be recovered from cultures of fibroblasts
obtained from normal skin. Although it is possible that the
activity seen in FCM may be due to a novel cytokine(s) or
to a newly recognized activity of already described factors,
the identification of the responsible molecule(s) remains un-
determined. Preliminary attempts to characterize the factor(s)
present in FCM indicated that the TVPA was stable at 4° C,
survived 1 h at 56°C, but was lost after treatment for 1 h
at pH >10 or <4. The activity was retained in a dialysis mem-
brane with a 5,000-dalton pore size.
A proposed Mechanismfor Retention ofPrimed T Cells.
￿
The
ability of fibroblasts and FCM to retain lymphocyte viability
could provide some clues as to the fate of activated T cells
after removal of antigen. As with the nonspecific cytokines
responsible for regulation of the induction phase of the cel-
lularimmune response, the cytokine(s) produced by the stromal
cells described in this report suggest a nonspecific mecha-
nism for retention of activated T cells. These factors can play
a role not only in the normal immune response, but could
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